The Malaria in Pregnancy (MiP) Consortium is partnering with WWARN to create a new Scientific Group. A number of new MiP Study Groups are underway to harness the statistical power of pooled analysis and address critical knowledge gaps relating to ... Read more
Much ado about Medicine Quality
WWARN’s Medicine Quality Group works to increase our understanding of the prevalence and distribution of poor quality medicines around the world. Find out how the Group is narrowing the knowledge gaps in information available on poor quality medicines, field testing ...Learn more
Explore our latest publications
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data BMC Medicine, 2015; 13(1): 212 Doi: 10.1186/s12916-015-0445-x PMID: 26343145 Read this and moreLearn more
Get involved with WWARN
WWARN invites scientists and clinical investigators working not just in malaria research, but other neglected tropical diseases to get involved in the collaboration. Find out how.Learn more
Watch our partners discuss their collaboration with WWARN
WWARN's video library gives an insight into how WWARN and partners are building capacity around the world and supporting the output of high quality dataLearn more
Data from 34 studies, including the latest results from Myanmar, are now live on the Molecular Surveyor pfmdr1 & pfcrt. This mapping tool tracks mutations that act as indicators of reduced malaria susceptibility to artemisinin partner drugs - lumefantrine, mefloquine ... Read more
WWARN is delighted to announce the appointment of Prof Oumar Gaye to lead the West Africa Regional Centre (WARC) together with Dr Magatte Ndiaye and Penda Touré from Université Cheikh Anta Diop, Dakar. The WARC supports researchers and public health ... Read more
To respond to the urgent need for novel drugs to address the scourge of drug resistance that is threatening highly effective antimalarials, WWARN has partnered with the Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) to ... Read more
The latest publication from the WWARN Gametocyte Study Group finds that the level of malaria transmission post-treatment varies depending on the type of ACT used. The study suggests that tailored treatment regimens could reduce the risk of continued malaria transmission ... Read more
A recent panel presentation comprising leading researchers and malaria-focused networks highlighted the importance of collaboration in tackling the challenges and roadblocks to malaria elimination. What do you think is the biggest challenge to elimination? Read more
On Monday, 25 April a group of leading researchers will mark World Malaria Day and the global drive to ‘End Malaria for Good’. Philippe Guérin from the WorldWide Antimalarial Resistance ...
Recorded 29 June 2015, Centre for Tropical Medicine and Global Health, University of Oxford Professor Kevin Marsh Senior Advisor, African Academy of Sciences and Professor of Tropical Medicine, University of ...